Surgery Partners, Inc. filed a current report on August 10, 2026, announcing financial results for the three and six months ended June 30, 2026, along with a scheduled investor conference call for the same date.

Key Highlights

  • Reporting period: Results cover both the three months and six months ended June 30, 2026.
  • Exchange listing: Surgery Partners common stock (par value $0.01 per share) trades on The Nasdaq Global Select Market under the ticker SGRY.
  • Conference call: An investor call was held August 10, 2026, at 8:30 a.m. Eastern Time to discuss second-quarter and first-half results.
  • Non-GAAP measures: The attached press release includes non-GAAP financial measures along with reconciliations to the most directly comparable GAAP financial measures.
  • Signatory: The filing was signed by David T. Doherty, Executive Vice President and Chief Financial Officer.
  • Exhibits furnished: The report includes a press release (Exhibit 99.1) and a Q2 2026 Earnings Presentation (Exhibit 99.2).

Surgery Partners Discloses Second-Quarter 2026 Earnings Filing Details

Surgery Partners, Inc., a Delaware-incorporated operator of surgical facilities headquartered at 340 Seven Springs Way, Suite 600, Brentwood, Tennessee 37027, filed this current report under Item 2.02, covering results of operations and financial condition. The company disclosed that a press release announcing results for the three and six months ended June 30, 2026, was issued on August 10, 2026, and attached as Exhibit 99.1 to the filing.

According to the filing, the information reported under Item 2.02, including Exhibit 99.1, is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. The company also noted that non-GAAP financial measures referenced in the press release are accompanied by reconciliations to the most directly comparable GAAP financial measures within that same document.

Under Item 7.01 (Regulation FD Disclosure), the company reported that an earnings presentation was made available and furnished as Exhibit 99.2. The filing similarly states that information furnished under Item 7.01, including Exhibit 99.2, is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into any filing under the Securities Act or the Exchange Act unless expressly stated. The company's Commission File Number is 001-37576, and its IRS Employer Identification Number is 47-3620923.

What Was Disclosed

Surgery Partners filed a current report on August 10, 2026, announcing second-quarter and first-half 2026 financial results via an attached press release and earnings presentation. A conference call was also held that morning. The filing was signed by Chief Financial Officer David T. Doherty.